Telephone sharing button Contact Us linkedin sharing button LinkedIn mailbox sharing button wuxixdc_info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Scientific Poster Download

Poster modified on 24/04/2026

Driving Dual-Payload ADC (dp-ADC) Development with Proprietary WuXiDARx™, X-LinC, and WuXiTecan-2

The next generation of ADCs are evolving through parallel innovations in target engagement and payload-linker innovations, dominated by bispecific ADC (BsADC) and dual-payload ADC(dp-ADC). Due to the increased complexity of such modality, these programs are calling for precise conjugation strategies, optimized payload-linker architectures, and improved control of physicochemical properties. To address these needs, WuXi XDC has built a platform through internal development and external collaboration.

 

The WuXiDARx Conjugation platform offers a flexible target DAR, flexible DAR choices for dual-payload ADC discovery, with a simple and scalable conjugation process. WuXiTecan2, a payload linker engineered to mitigate exatecan-associated hydrophobicity, enabled dual-payload ADC screening paired with TOP1i with favorable chemical properties.

 

As a dedicated CRDMO, WuXi XDC provides innovative technology platforms to help clients accelerating next-gen ADC discovery and development.

                   

Discuss This Poster

To discuss the data in this poster, please complete the form on the following page to connect with our experts.

Connect with our Experts

Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?